Trillium™ Biopassive Surface: A New Biocompatible Treatment for Extracorporeal Circulation Circuits

Abstract

139 patients undergoing cardiac surgery were included in a prospective, randomized trial. Patients were randomly allocated to receive cardiopulmonary bypass (CPB) with Trillium™ Biopassive Surface (TBS Group) coated oxygenators or conventional circuits (control group).

112 patients were studied with respect to postoperative biochemical profile; a subgroup of 27 patients was studied with respect to perioperative complement (C3a) activation.

Patients in the TBS group demonstrated a significantly lower white blood cell count at the end of the operation (p=0.036) and a significantly higher platelet count the day after the operation (p=0.023) when compared to the control group. C3a was significantly higher (p=0.02) in the TBS group after 30 minutes of CPB, but the C3a increase after protamine administration was significantly less pronounced in the TBS group vs. the control group.

Further studies involving platelet and leukocyte activation are required to better elucidate the action of this new coating in the setting of routine CPB.

Keywords

Cardiopulmonary bypass Complement activation Biocompatible materials

Get full access to this article

View all access options for this article.

References

Videm

, Mollnes

T.E.

, Garred

, Svennevig

J.L.

. Biocompatibility of extracorporeal circulation. In vitro comparison of heparin-coated and uncoated oxygenator circuits. J Thorac Cardiovasc Surg 1991; 101: 654–60.

Y.J.

, van Oeveren

, Akkerman

, Boonstra

P.W.

, Huyzen

R.J.

, Wildevuur

C.R.H.

. Heparin-coated circuits reduce the inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 1993; 55: 917–22.

Moen

, Fosse

, Brockmeier

, Andersson

. Disparity in blood activation by two different heparin-coated cardiopulmonary bypass systems. Ann Thorac Surg 1995; 60: 1317–23.

Ovrum

, Mollnes

T.E.

, Fosse

. Complement and granulocyte activation in two different types of heparinized extracorporeal circuits. J Thorac Cardiovasc Surg 1995; 110: 1623–32.

Fukutomi

, Kobayashi

, Niwaya

, Hamada

, Kitamura

. Changes in platelet, granulocyte, and complement activation during cardiopulmonary bypass using heparin-coated equipment. Artif Organs 1996; 20: 767–76.

Korn

R.L.

, Fisher

C.A.

, Livingston

E.R.

. The effects of Carmeda Bioactive Surface on human blood components during simulated extracorporeal circulation. J Thorac Cardiovasc Surg 1996; 111: 1073–84.

Moen

, Hogasen

, Fosse

. Attenuation of changes in leukocyte surface markers and complement activation with heparin-coated cardiopulmonary bypass. Ann Thorac Surg 1997; 63: 105–11.

Wildevuur

C.R.H.

, Jansen

P.G.M.

, Bezemer

P.D.

. Clinical evaluation of Duraflo II heparin treated extracorporeal circulation circuits. The European working group on heparin coated extracorporeal circulation circuits. Eur J Cardiothorac Surg 1997; 11: 616–23.

Ranucci

, Cirri

, Conti

. Beneficial effects of Duraflo II heparin coated circuits on postperfusion lung dysfunction. Ann Thorac Surg 1996; 61: 76–81.

10.

Jansen

P.G.M.

, Baufreton

, Le Besnerais

, Loisance

D.Y.

, Wildevuur

C.R.H.

. Heparin-coated circuits and aprotinin prime for coronary artery bypass grafting. Ann Thorac Surg 1996; 61: 1363–6.

11.

Ranucci

, Mazzucco

, Pessotto

. Heparin-coated circuits for high-risk patients: a multicenter, prospective, randomized trial. Ann Thorac Surg 1999; 67: 994–1000.

12.

Aldea

G.S.

, O'Gara

, Shapira

O.M.

. Effect of anticoagulation protocol on outcome in patients undergoing CABG with heparin-bonded cardiopulmonary bypass circuits. Ann Thorac Surg 1998; 65: 425–33.

13.

Ovrum

, Am Holen

, Tangen

. Completely heparinized cardiopulmonary bypass and reduced systemic heparin: clinical and hemostatic effects. Ann Thorac Surg 1995; 60: 365–71.

14.

Yii

, Gourlay

, Fleming

, Matata

, Taylor

K.M.

. Evaluation of Carmeda Bioactive Surface (CBAS), Duraflo II and a novel nonspecific preotease-modified surface using a new in vitro model simulating cardiopulmonary bypass. Perfusion 1996; 11: 229–40.